These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8991935)

  • 21. CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus.
    Wang EC; Moss PA; Frodsham P; Lehner PJ; Bell JI; Borysiewicz LK
    J Immunol; 1995 Nov; 155(10):5046-56. PubMed ID: 7594513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
    Purtha WE; Myers N; Mitaksov V; Sitati E; Connolly J; Fremont DH; Hansen TH; Diamond MS
    Eur J Immunol; 2007 Jul; 37(7):1845-54. PubMed ID: 17559174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans.
    Sztein MB; Tanner MK; Polotsky Y; Orenstein JM; Levine MM
    J Immunol; 1995 Oct; 155(8):3987-93. PubMed ID: 7561107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL.
    Hegde NR; Dunn C; Lewinsohn DM; Jarvis MA; Nelson JA; Johnson DC
    J Exp Med; 2005 Oct; 202(8):1109-19. PubMed ID: 16216889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93.
    Liu YN; Curtsinger J; Donahue PR; Klaus A; Optiz G; Cooper J; Karr RW; Bach FH; Gehrz RC
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2207-14. PubMed ID: 7691989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells.
    Navarro D; Paz P; Tugizov S; Topp K; La Vail J; Pereira L
    Virology; 1993 Nov; 197(1):143-58. PubMed ID: 7692667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirus-infected endothelial cells: role of MHC class I antigens.
    Weinberg A; Zhang L; Hayward AR
    Viral Immunol; 2000; 13(1):37-47. PubMed ID: 10733167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus.
    Yamashita Y; Shimokata K; Mizuno S; Yamaguchi H; Nishiyama Y
    Virology; 1993 Apr; 193(2):727-36. PubMed ID: 8384753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity.
    Gönczöl E; deTaisne C; Hirka G; Berencsi K; Lin WC; Paoletti E; Plotkin S
    Vaccine; 1991 Sep; 9(9):631-7. PubMed ID: 1659051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary exploration of HLA-A 1101-restricted human cytomegalovirus glycoprotein B-specific CD8⁺ T cells in allogeneic stem-cell transplant recipients.
    Liu A; Hu J; Wu W; Huang Y; Liang H; Wang H; Yang R; Fan J
    Virus Res; 2014 Aug; 188():38-44. PubMed ID: 24704672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate.
    Gönczöl E; Berensci K; Pincus S; Endresz V; Méric C; Paoletti E; Plotkin SA
    Vaccine; 1995 Aug; 13(12):1080-5. PubMed ID: 7491815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.
    Alp NJ; Allport TD; Van Zanten J; Rodgers B; Sissons JG; Borysiewicz LK
    J Virol; 1991 Sep; 65(9):4812-20. PubMed ID: 1714519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens.
    Shepp DH; Daguillard F; Mann D; Quinnan GV
    AIDS; 1988 Apr; 2(2):113-7. PubMed ID: 2454643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus.
    Zhong J; Rist M; Cooper L; Smith C; Khanna R
    PLoS One; 2008 Sep; 3(9):e3256. PubMed ID: 18806877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons.
    Mbawuike IN; Lange AR; Couch RB
    Viral Immunol; 1993; 6(1):55-64. PubMed ID: 8476508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited Effector Memory B-Cell Response to Envelope Glycoprotein B During Primary Human Cytomegalovirus Infection.
    Dauby N; Sartori D; Kummert C; Lecomte S; Haelterman E; Delforge ML; Donner C; Mach M; Marchant A
    J Infect Dis; 2016 May; 213(10):1642-50. PubMed ID: 26715677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes.
    Warren AP; Ducroq DH; Lehner PJ; Borysiewicz LK
    J Virol; 1994 May; 68(5):2822-9. PubMed ID: 8151753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers.
    Gonczol E; Ianacone J; Ho WZ; Starr S; Meignier B; Plotkin S
    Vaccine; 1990 Apr; 8(2):130-6. PubMed ID: 2159679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.
    Meng W; Tang A; Ye X; Gui X; Li L; Fan X; Schultz RD; Freed DC; Ha S; Wang D; Zhang N; Fu TM; An Z
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.